e142 |
Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
Junshik Hong, Soo-Mee Bang, Yeung-Chul Mun, Ho-Young Yhim, Jaehoon Lee, Hyeong-Seok Lim, Doyeun Oh, Junshik Hong, Soo-Mee Bang, Yeung-Chul Mun, Ho-Young Yhim, Jaehoon Lee, Hyeong-Seok Lim, Doyeun Oh,
KMSID: 1108416 J Korean Med Sci. 2018;33(19):e142. Published online 2018 April 24 DOI: http://dx.doi.org/10.3346/jkms.2018.33.e142 |
e143 |
Consensus Statements by Korean Society of Interventional Neuroradiology and Korean Stroke Society: Hyperacute Endovascular Treatment Workflow to Reduce Door-to-Reperfusion TimeConsensus Statements by Korean Society of Interventional Neuroradiology and Korean Stroke Society: Hyperacute Endovascular Treatment Workflow to Reduce Door-to-Reperfusion Time
Dae-Hyun Kim, Byungjun Kim, Cheolkyu Jung, Hyo Suk Nam, Jin Soo Lee, Jin Woo Kim, Woong Jae Lee, Woo-Keun Seo, Ji-Hoe Heo, Seung Kug Baik, Byung Moon Kim, Joung-Ho Rha, Dae-Hyun Kim, Byungjun Kim, Cheolkyu Jung, Hyo Suk Nam, Jin Soo Lee, Jin Woo Kim, Woong Jae Lee, Woo-Keun Seo, Ji-Hoe Heo, Seung Kug Baik, Byung Moon Kim, Joung-Ho Rha,
KMSID: 1107799 J Korean Med Sci. 2018;33(19):e143. Published online 2018 April 26 DOI: http://dx.doi.org/10.3346/jkms.2018.33.e143 |